Net Loss per Share

6 Months Ended

Jun. 30, 2026

13. Net Loss per Share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows:


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Numerator:
Net loss	$	(6,375	)	$	(6,822	)	$	(12,213	)	$	(12,323	)
Denominator:
Weighted average common shares outstanding—basic and diluted		67,084,661			24,187,536			48,821,118			23,057,920
Net loss per share attributable to common stockholders—basic and diluted	$	(0.10	)	$	(0.28	)	$	(0.25	)	$	(0.53	)

As part of the April 2025 Transactions, the Pre-Funded Warrants to purchase an aggregate of 2,251,695 shares of common stock at an exercise price of $0.001 per share are included within the denominator for basic net loss per share purposes and considered outstanding as of the date of issuance.

The Company’s potential dilutive securities, which include stock options as of June 30, 2026 and 2025, have been excluded from the computation of diluted net loss per share attributable to common stockholders whenever the effect of including them would be to reduce the net loss per share. In periods where there is a net loss, the weighted average number of shares of common stock outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The following potential shares of common stock, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:


	Six Months Ended June 30,
	2026		2025
Options to purchase common stock		3,545,997		3,065,029
Warrants to issue shares of common stock		11,346,839		6,616,499
Series X Preferred Stock issued and outstanding, as converted		12,232,000		12,232,000
Total		27,124,836		21,913,528